1. Home
  2. EIG vs INBX Comparison

EIG vs INBX Comparison

Compare EIG & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$43.53

Market Cap

754.0M

Sector

Finance

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$103.07

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
INBX
Founded
2000
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.0M
999.7M
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
EIG
INBX
Price
$43.53
$103.07
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$150.00
AVG Volume (30 Days)
170.1K
442.3K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$858,700,000.00
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.26
N/A
P/E Ratio
$83.12
N/A
Revenue Growth
N/A
550.00
52 Week Low
$35.73
$12.80
52 Week High
$48.83
$155.29

Technical Indicators

Market Signals
Indicator
EIG
INBX
Relative Strength Index (RSI) 57.96 45.50
Support Level $41.01 $99.20
Resistance Level $44.38 $153.14
Average True Range (ATR) 0.95 11.61
MACD 0.09 -3.13
Stochastic Oscillator 73.38 7.41

Price Performance

Historical Comparison
EIG
INBX

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: